Hua Xi Bio responds to recent turmoil: collagen and "recombinant" collagen are not the same concept.

Jin10 reported on June 3 that Huaxi Bio responded to reporters regarding the controversy over recombinant collagen with Giant Bio, stating that their opposition is to the name game of "recombinant" collagen, not to the scientific research and industrial transformation of collagen. The company places more importance on the interaction between HA and collagen in ECM, and pointed out that the credibility of domestic brands should not be built on the abuse of concepts, hoping the industry can return to the issue of product quality and seek solutions.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate app
Community
English
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)